May 2026 – Kinstellar has recently advised Raiffeisen Bank International on the provision of a double-digit million-euro growth financing to REPLOID Group, an Austrian biotechnology company.
The financing represents a strong endorsement of REPLOID’s scalable and profitable business model, which focuses on the conversion of organic residual materials. By combining circular economy principles with advanced insect technology, REPLOID produces high-quality proteins, fats, and organic fertilisers, addressing a rapidly growing market of strategic importance for a more sustainable economy.
Scale-up banking is a relatively new product in the Austrian market, and Kinstellar combined its financing experience with Raiffeisen Bank International AG's expertise in this new market to bring this landmark transaction over the finish line.
Kinstellar’s team was led by Laurenz Liedermann (Partner) with support from Florian Sesztak (Associate), working together with Ilja Baudisch (Partner) and Till Kotterer-Rädecke (Associate) from SZA Schilling, Zutt & Anschütz.